 | Design Therapeutics, Inc. | |||
| NMS : DSGN || Location: United States | ||||
$3.65-0.01 (-0.27%) |
0.19 M | 3.56 - 3.73 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 2.390 M |
| March 28, 2024 | 2.231 M |
| March 15, 2024 | 2.142 M |
| Feb. 29, 2024 | 2.851 M |
| Feb. 15, 2024 | 2.821 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.32 | -0.21 | 33.52% |
| 09/30/2023 | -0.42 | -0.28 | 32.81% |
| 06/30/2023 | -0.41 | -0.36 | 11.22% |
| 03/31/2023 | -0.37 | -0.35 | 4.48% |
| 12/31/2022 | -0.35 | -0.31 | 11.66% |
DSGN Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 56.494M | Shares Float | 24.141M |
| Short Float | 2.390M | Market Cap | 206.20M |
| Institution ownership | 56.56% | Insider ownership | 36.668% |
| Earnings Date | 05/06/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -1.19 | Forward EPS | -1.40 |